PIOGLITAZONE
- Product NDC
- 61919-781
- 11-digit product format
- 619190781
- Labeler code
- 61919
- Product ID
- 61919-781_87d414ba-6440-0dd8-e053-2a95a90a36ae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PIOGLITAZONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- DirectRX
- Application
- ANDA200044
- Marketing category
- ANDA
- Marketing start
- 2019-05-01
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-781-30 | 61919078130 | 30 TABLET in 1 BOTTLE (61919-781-30) | 30 tablet | 2019-05-01 | 0000-00-00 | No | No | Current |
| 61919-781-90 | 61919078190 | 90 TABLET in 1 BOTTLE (61919-781-90) | 90 tablet | 2019-01-14 | 0000-00-00 | No | No | Current |